American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

@article{Kris2006AmericanSO,
  title={American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.},
  author={Mark G. Kris and Paul Joseph Hesketh and Mark R. Somerfield and Petra Ch Feyer and Rebecca Anne Clark-Snow and James M Koeller and Gary R. Morrow and Lawrence W Chinnery and Maurice J Chesney and Richard J. Gralla and Steven M. Grunberg},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 18},
  pages={2932-47}
}
PURPOSE To update the 1999 American Society of Clinical Oncology guideline for antiemetics in oncology. UPDATE METHODOLOGY The Update Committee completed a review and analysis of data published from 1998 thru February 2006. The literature review focused on published randomized controlled trials, and systematic reviews and meta-analyses of published phase II and phase III randomized controlled trials. RECOMMENDATIONS The three-drug combination of a 5-hydroxytryptamine-3 (5-HT(3)) serotonin… CONTINUE READING
Highly Influential
This paper has highly influenced a number of papers. REVIEW HIGHLY INFLUENTIAL CITATIONS